Millennium Management’s BioVie BIVI Stock Holding History

Millennium Management’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12,262	Closed	-$245K	–	5872
2024 Q4	$245K	Buy	+12,262	New	+$296K	﹤0.01%	5190
2024 Q2	–	Sell	-131	Closed	-$6.95K	–	5902
2024 Q1	$6.95K	Sell	131 -239	-65%	-$24.5K	﹤0.01%	5975
2023 Q4	$46.6K	Sell	370 -223	-38%	-$67K	﹤0.01%	5491
2023 Q3	$202K	Sell	593 -2,754	-82%	-$1.08M	﹤0.01%	5124
2023 Q2	$1.44M	Buy	3,347 +3,002	+870%	+$2.02M	﹤0.01%	3746
2023 Q1	$279K	Sell	345 -917	-73%	-$608K	﹤0.01%	4963
2022 Q4	$981K	Buy	+1,262	New	+$682K	﹤0.01%	4185
2021 Q2	–	Sell	-231	Closed	-$447K	–	6534
2021 Q1	$447K	Sell	231 -9	-4%	-$25.7K	﹤0.01%	4910
2020 Q4	$416K	Buy	+240	New	+$240K	﹤0.01%	4341

Other funds holding BIVI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management's BIVI Position: Q1 2025 in Review

Millennium Management sold out of BioVie (BIVI) in Q1 2025, closing a stake of 12,262 shares — an estimated $245K sold.

Millennium Management first reported a position in BIVI in Q4 2020 and held it in 9 quarters. The position peaked at $1.44M in Q2 2023. 37 funds tracked by Wall St. Rank hold BIVI as of Q1 2025.

Millennium Management reported no remaining BioVie position as of Q1 2025 after selling out during the quarter.
Millennium Management sold 12,262 BioVie shares in Q1 2025, an estimated $245K.
Millennium Management first reported a position in BioVie in Q4 2020 and held it in 9 quarters.
Millennium Management's BioVie position peaked at $1.44M in Q2 2023.
37 funds tracked by Wall St. Rank held BioVie as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.